Tara A Lavelle

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Insulin Resistance

Decision Making

Top Venues

Health affairs scholar

Applied health economics and health policy

PharmacoEconomics

Medical decision making : an international journal of the Society for Medical Decision Making

This page only lists publications with an associated author ORCID identifier.

Publications

Deborah A Marshall, Nicolle Hua, James Buchanan, Kurt D Christensen, Geert W J Frederix, Ilias Goranitis, Maarten J IJzerman, Jeroen P Jansen, Tara A Lavelle, Deirdre Weymann, Hadley Stevens Smith, Wendy J Ungar, Deirdre Weymann, Sarah Wordsworth, Kathryn A Phillips
Paving the path for implementation of clinical genomic sequencing globally: Are we ready? Health affairs scholar 2 (5) (2024)
Deborah A Marshall, Nicolle Hua, James Buchanan, Kurt D Christensen, Geert W J Frederix, Ilias Goranitis, Maarten J IJzerman, Jeroen P Jansen, Tara A Lavelle, Deirdre Weymann, Hadley Stevens Smith, Wendy J Ungar, Deirdre Weymann, Sarah Wordsworth, Kathryn A Phillips
Paving the path for implementation of clinical genomic sequencing globally: Are we ready? Health affairs scholar 2 (5) (2024)
Ching-Hsuan Lin, Tara A Lavelle, Marie C Phillips, Abigail G Riley, Daniel A Ollendorf
Public deliberation on health gain measures. Health affairs scholar 2 (9) (2024)
Ankur Pandya, Mike Paulden, Jinyi Zhu, Tara A Lavelle, James Hammitt
Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates. Medical decision making : an international journal of the Society for Medical Decision Making 42 (7) (2022)
Tara A Lavelle, Milton C Weinstein, Joseph P Newhouse, Kerim Munir, Karen A Kuhlthau, Lisa A Prosser
Parent Preferences for Health Outcomes Associated with Autism Spectrum Disorders. PharmacoEconomics 37 (4) (2020)
Tara A Lavelle, Brittany N D'Cruz, Babak Mohit, Wendy J Ungar, Lisa A Prosser, Kate Tsiplova, Montserrat Vera-Llonch, Pei-Jung Lin
Family Spillover Effects in Pediatric Cost-Utility Analyses. Applied health economics and health policy 17 (2) (2020)